Changes in myofilament proteins, but not Ca²⁺ regulation, are associated with a high-fat diet-induced improvement in

Y Cheng1, W Li, T A McElfresh

  • 1Department of Physiology and Biophysics, Case Western Reserve University, Cleveland, Ohio 44106-4970, USA.

Insights

High saturated fat diets may protect the heart in heart failure (HF) by improving cardiomyocyte function. This study found saturated fat feeding improved contractile function and prevented detrimental protein changes in HF rats.

Area of Science:

  • Cardiology
  • Physiology
  • Biochemistry

Background:

  • Heart failure (HF) is often worsened by high lipid levels, impacting cardiac contractility.
  • Previous research suggests high saturated fat (SAT) diets may offer cardioprotection in HF.

Purpose of the Study:

  • To investigate if SAT feeding improves heart function in HF by altering cardiomyocyte calcium (Ca2+) regulation and myofilament proteins.
  • To test the hypothesis that SAT intake enhances cardiac contractility through these mechanisms.

Main Methods:

  • Male Wistar rats were subjected to coronary ligation (HF) or sham surgery (SH).
  • Groups were fed either normal chow or a SAT diet for 8 weeks.
  • In vivo and isolated cardiomyocyte contractile properties were assessed, alongside protein analysis.

Main Results:

  • HF rats on normal chow showed depressed cardiac function, which improved with SAT feeding (HFSAT group).
  • SAT feeding reduced cardiomyocyte hypertrophy and preserved peak shortening velocity in HF rats.
  • A shift in myosin heavy chain (MHC) isoforms in HF was prevented by SAT diet, suggesting myofilament adaptation.

Conclusions:

  • SAT feeding demonstrates cardioprotective effects in HF, primarily by improving myofilament function at the cardiomyocyte level.
  • These benefits appear independent of changes in sarcoplasmic reticulum Ca2+ regulatory proteins.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Smooth Muscle Contraction01:25

Smooth Muscle Contraction

Smooth muscle contraction is a complex process vital for various bodily functions, from maintaining blood vessel tension to facilitating the movement of food through the digestive tract. Unlike striated muscles, smooth muscle contraction begins more slowly and lasts longer.
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...